Published on 29 Apr 2024 on Benzinga
MorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an experimental myelofibrosis treatment.
Myelofibrosis is a type of blood cancer characterized by the buildup of scar tissue, called “fibrosis,” in the bone marrow.